Literature DB >> 10089347

Structure of recombinant human lactoferrin expressed in Aspergillus awamori.

X L Sun1, H M Baker, S C Shewry, G B Jameson, E N Baker.   

Abstract

Human lactoferrin (hLf) has considerable potential as a therapeutic agent. Overexpression of hLf in the fungus Aspergillus awamori has resulted in the availability of very large quantities of this protein. Here, the three-dimensional structure of the recombinant hLf has been determined by X-ray crystallography at a resolution of 2.2 A. The final model, comprising 5339 protein atoms (residues 1-691, 294 solvent molecules, two Fe3+and two CO32- ions), gives an R factor of 0.181 (free R = 0.274) after refinement against 32231 reflections in the resolution range 10-2.2 A. Superposition of the recombinant hLf structure onto the native milk hLf structure shows a very high level of correspondence; the main-chain atoms for the entire polypeptide can be superimposed with an r.m.s. deviation of only 0.3 A and there are no significant differences in side-chain conformations or in the iron-binding sites. Dynamic properties, as measured by B-value distributions or iron-release kinetics, also agree closely. This shows that the structure of the protein is not affected by the mode of expression, the use of strain-improvement procedures or the changes in glycosylation due to the fungal system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089347     DOI: 10.1107/s0907444998011226

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  14 in total

1.  A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.

Authors:  Falk Duchardt; Ivo R Ruttekolk; Wouter P R Verdurmen; Hugues Lortat-Jacob; Jochen Bürck; Hansjörg Hufnagel; Rainer Fischer; Maaike van den Heuvel; Dennis W P M Löwik; Geerten W Vuister; Anne Ulrich; Michel de Waard; Roland Brock
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

2.  The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin.

Authors:  Ellen A J Thomassen; Harrie A van Veen; Patrick H C van Berkel; Jan H Nuijens; Jan Pieter Abrahams
Journal:  Transgenic Res       Date:  2005-08       Impact factor: 2.788

Review 3.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 4.  The role of talactoferrin alpha in the treatment of non-small cell lung cancer.

Authors:  Ronan J Kelly; Giuseppe Giaccone
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

Review 5.  Transition metals at the host-pathogen interface: how Neisseria exploit human metalloproteins for acquiring iron and zinc.

Authors:  Wilma Neumann; Rose C Hadley; Elizabeth M Nolan
Journal:  Essays Biochem       Date:  2017-05-09       Impact factor: 8.000

Review 6.  Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality.

Authors:  Ronan J Kelly; James L Gulley; Giuseppe Giaccone
Journal:  Clin Lung Cancer       Date:  2010-07-01       Impact factor: 4.785

Review 7.  Lactoferrin for prevention of neonatal sepsis.

Authors:  Christie G Turin; Alonso Zea-Vera; Alonso Pezo; Karen Cruz; Jaime Zegarra; Sicilia Bellomo; Luis Cam; Raul Llanos; Anne Castañeda; Lourdes Tucto; Theresa J Ochoa
Journal:  Biometals       Date:  2014-06-17       Impact factor: 2.949

8.  Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism.

Authors:  Olga Senkovich; William J Cook; Shaper Mirza; Susan K Hollingshead; Irina I Protasevich; David E Briles; Debasish Chattopadhyay
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

9.  Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences.

Authors:  Elena Campione; Caterina Lanna; Terenzio Cosio; Luigi Rosa; Maria Pia Conte; Federico Iacovelli; Alice Romeo; Mattia Falconi; Claudia Del Vecchio; Elisa Franchin; Maria Stella Lia; Marilena Minieri; Carlo Chiaramonte; Marco Ciotti; Marzia Nuccetelli; Alessandro Terrinoni; Ilaria Iannuzzi; Luca Coppeda; Andrea Magrini; Sergio Bernardini; Stefano Sabatini; Felice Rosapepe; Pier Luigi Bartoletti; Nicola Moricca; Andrea Di Lorenzo; Massimo Andreoni; Loredana Sarmati; Alessandro Miani; Prisco Piscitelli; Piera Valenti; Luca Bianchi
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

10.  Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins.

Authors:  Valeriya R Samygina; Alexey V Sokolov; Gleb Bourenkov; Maxim V Petoukhov; Maria O Pulina; Elena T Zakharova; Vadim B Vasilyev; Hans Bartunik; Dmitri I Svergun
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.